miR-320 targets ETS2, a transcription factor that regulates the expression of several genes important to leukocyte extravasation post-stroke including MMP-9, MMP-3, MMP-13, ANGPT1, and TNF [29], [30]. This evidence concerns the gene MMP13 and stroke disorder.